ReP USP - Resultado da busca

Trabalho de evento-resumo
Metformin treatment improves vascular function in rats with neonatal streptozotocin-induced type 2 diabetes (2003)
Sartoretto, Juliano Luiz; Carvalho, Maria Helena Catelli de; Nigro, Dorothy; Passaglia, Rita de Cássia Aleixo Tostes; Cuman, Roberto Kenji Nakamura; Fortes, Zuleica Bruno
Source: Program and Abstract Book. Conference titles: Scientific Meeting of the Inter-American Society of Hypertension. Unidade: ICB
Assunto: FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SARTORETTO, Juliano Luiz et al. Metformin treatment improves vascular function in rats with neonatal streptozotocin-induced type 2 diabetes. 2003, Anais.. San Diego: Inter-American Society of Hypertension, 2003. . Acesso em: 06 nov. 2024.
APA
Sartoretto, J. L., Carvalho, M. H. C. de, Nigro, D., Passaglia, R. de C. A. T., Cuman, R. K. N., & Fortes, Z. B. (2003). Metformin treatment improves vascular function in rats with neonatal streptozotocin-induced type 2 diabetes. In Program and Abstract Book. San Diego: Inter-American Society of Hypertension.
NLM
Sartoretto JL, Carvalho MHC de, Nigro D, Passaglia R de CAT, Cuman RKN, Fortes ZB. Metformin treatment improves vascular function in rats with neonatal streptozotocin-induced type 2 diabetes. Program and Abstract Book. 2003 ;[citado 2024 nov. 06 ]
Vancouver
Sartoretto JL, Carvalho MHC de, Nigro D, Passaglia R de CAT, Cuman RKN, Fortes ZB. Metformin treatment improves vascular function in rats with neonatal streptozotocin-induced type 2 diabetes. Program and Abstract Book. 2003 ;[citado 2024 nov. 06 ]
Trabalho de evento
Blockade of ETA receptor decreases renal damage in doca-salt hypertension, but not increasead expression of adhesion molecules (2003)
Callera, Glaucia; Montezano, Augusto C. I.; Zorn, Telma; Carvalho, Maria Helena Catelli de; Fortes, Zuleica Bruno; Nigro, Dorothy; Passaglia, Rita de Cássia Aleixo Tostes
Source: Program and Abstract Book. Conference titles: Scientific Meeting of the Inter-American Society of Hypertension. Unidade: ICB
Assunto: FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CALLERA, Glaucia et al. Blockade of ETA receptor decreases renal damage in doca-salt hypertension, but not increasead expression of adhesion molecules. 2003, Anais.. San Antonio: Instituto de Ciências Biomédicas, Universidade de São Paulo, 2003. . Acesso em: 06 nov. 2024.
APA
Callera, G., Montezano, A. C. I., Zorn, T., Carvalho, M. H. C. de, Fortes, Z. B., Nigro, D., & Passaglia, R. de C. A. T. (2003). Blockade of ETA receptor decreases renal damage in doca-salt hypertension, but not increasead expression of adhesion molecules. In Program and Abstract Book. San Antonio: Instituto de Ciências Biomédicas, Universidade de São Paulo.
NLM
Callera G, Montezano ACI, Zorn T, Carvalho MHC de, Fortes ZB, Nigro D, Passaglia R de CAT. Blockade of ETA receptor decreases renal damage in doca-salt hypertension, but not increasead expression of adhesion molecules. Program and Abstract Book. 2003 ;[citado 2024 nov. 06 ]
Vancouver
Callera G, Montezano ACI, Zorn T, Carvalho MHC de, Fortes ZB, Nigro D, Passaglia R de CAT. Blockade of ETA receptor decreases renal damage in doca-salt hypertension, but not increasead expression of adhesion molecules. Program and Abstract Book. 2003 ;[citado 2024 nov. 06 ]
Trabalho de evento-resumo
Selective cyclooxygenase-2 inhibition with etoricoxib elevates blood pressure and alters vascular reactivity (2003)
Fernandes, Lilian; Méndez Salvatierra, D. E; Teixeira, Simone Aparecida; Martinez, Luís Lopes; Fortes, Zuleica Bruno; Carvalho, Maria Helena Catelli de; Muscará, Marcelo Nicolás
Source: Program and Abstract Book. Conference titles: Scientific Meeting of the Inter-American Society of Hypertension. Unidade: ICB
Assunto: FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERNANDES, Lilian et al. Selective cyclooxygenase-2 inhibition with etoricoxib elevates blood pressure and alters vascular reactivity. 2003, Anais.. San Antonio: Instituto de Ciências Biomédicas, Universidade de São Paulo, 2003. . Acesso em: 06 nov. 2024.
APA
Fernandes, L., Méndez Salvatierra, D. E., Teixeira, S. A., Martinez, L. L., Fortes, Z. B., Carvalho, M. H. C. de, & Muscará, M. N. (2003). Selective cyclooxygenase-2 inhibition with etoricoxib elevates blood pressure and alters vascular reactivity. In Program and Abstract Book. San Antonio: Instituto de Ciências Biomédicas, Universidade de São Paulo.
NLM
Fernandes L, Méndez Salvatierra DE, Teixeira SA, Martinez LL, Fortes ZB, Carvalho MHC de, Muscará MN. Selective cyclooxygenase-2 inhibition with etoricoxib elevates blood pressure and alters vascular reactivity. Program and Abstract Book. 2003 ;[citado 2024 nov. 06 ]
Vancouver
Fernandes L, Méndez Salvatierra DE, Teixeira SA, Martinez LL, Fortes ZB, Carvalho MHC de, Muscará MN. Selective cyclooxygenase-2 inhibition with etoricoxib elevates blood pressure and alters vascular reactivity. Program and Abstract Book. 2003 ;[citado 2024 nov. 06 ]

USP Schools

ReP

Filtros

Authors

USP affiliated authors